Top News

• Top Drug Chief Resigns Amid Misconduct Probe, Lawsuit
• Interchangeability Status on Celltrion Biosimilars
• Safety Data Update on Hintermann Ankle Device
• Lilly Hopeful Obesity Pill Accepted in Voucher Program
• J&J Seeks Stelara Expanded Use
• FDA to Unveil Faster Pathway for Gene-Editing Therapies
• FDA Moves to Restrict Unapproved Fluoride Drugs
• Senators Want Foreign Generic Drug Info